433938-50-2

Basic information

• Product Name: Carbamic acid, [[4-[[[[(2S)-1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-2- azetidinyl]carbonyl]amino]methyl]phenyl]iminomethyl]-, 2-(trimethylsilyl)ethyl ester
• CAS NO: 433938-50-2
• Molecular Formula: C27H32ClF3N4O6Si
• Molecular Weight: 629.108
• Mol File: 433938-50-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [[4-[[[[(2S)-1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-2- azetidinyl]carbonyl]amino]methyl]phenyl]iminomethyl]-, 2-(trimethylsilyl)ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [[4-[[[[(2S)-1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-2- azetidinyl]carbonyl]amino]methyl]phenyl]iminomethyl]-, 2-(trimethylsilyl)ethyl ester(433938-50-2)
• EPA Substance Registry System: Carbamic acid, [[4-[[[[(2S)-1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-2- azetidinyl]carbonyl]amino]methyl]phenyl]iminomethyl]-, 2-(trimethylsilyl)ethyl ester(433938-50-2)

Safety Data

• Hazardous Substances Data: 433938-50-2(Hazardous Substances Data)

Upstream product

• 433938-49-9 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)OH 
• 218598-31-3 H-Aze-Pab(Teoc) 

Downstream Products

• 433937-81-6 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab-(OCH₂-3-(5-Me-isoxazole)) 
• 433938-53-5 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OEt) 
• 433938-55-7 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OcHexyl) 
• 433938-54-6 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OBn) 
• 433938-52-4 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OiBu) 
• 433938-61-5 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OBn(4-Me)) 
• 433938-60-4 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OBn(2-Br)) 
• 433938-57-9 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OCH₂CH₂OPh(3-CF₃)) 
• 433938-51-3 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OCH₂-3-pyridine) 
• 433938-56-8 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OcBu) 
• 433937-81-6 Ph(3-Cl)(5-OCF₃)-(R)CH(OH)C(O)-Aze-Pab(OCH₂-3-(5-Me-isoxazole)) 

Relevant articles and documents

Mandelic acid derivatives and their use as throbin inhibitors

There is provided a compound of formula I wherein Ra, R1, R2, Y and R3 have meanings given in the description and pharmaceutically acceptable derivatives (including prodrugs) thereof, which compounds and derivatives are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.